Ind-Swift Laboratories Lt

68.90

+1.10 (1.62%)

BSE

Buy Sell

NSE BSE

Last updated on 29 Dec 2021 10:11 AM

Invest in Stocks for FREE*

Invest and trade in your favourite companies

Open Demat account

Returns

2.99%

Loading chart...

Fundamentals

Large Cap

Financial - Banking

Market Cap (Cr)

400.61

Earning Per Share

-0.74

Dividend Yield

P/E Ratio

P/B Ratio

0.85

Debt to Equity

2.39

Performance

min-value

max-value

Open

56,601.30

52-wk High

75,250.00

High

56,601.30

52-wk Low

75,250.00

Low

56,601.30

Band

75,250.00

Lower Circuit

56,601.30

Upper Circuit

75,250.00

Volume

56,601.30

VWAP

75,250.00

52 Week Performance

min-value

max-value

5.34% down side

up side5.34%

About the company

Ind-Swift Laboratories Ltd is a part of the Ind-swift Group and is based at Chandigarh, India. The company manufactures and sells active pharmaceutical ingredients (API). Their product pipeline consists of 25 products, which includes drugs, which include Clarithromycin (Macrolide antibiotic), Atorvastatin (anticholestrol), Fexofenadine (antihistamine), Clopidogrel (anticholestrol), Nitazoxanide (antidiarrheal), Pioglitazone (antidiabetic), Letrozole and Anastrozole (anticancer), Venlafaxine (antidepressants) and Quetipine and Aripirazole (antipsychotic). The company has one subsidiary namely, Ind-Swift Laboratories Inc in USA. Ind-Swift Laboratories Ltd was incorporated in the year 1995 as a joint venture between Ind-Swift Ltd and Punjab State Industrial Development Corporation.

Similar Companies

Piramal Enterprises

2629.3 +31.50 (0.01%)

1Yr Returns

+82.14%

IPCA Laboratories

2085.55 +2.15 (0.00%)

1Yr Returns

-3.93%

Natco Pharma

897.95 +6.35 (0.01%)

1Yr Returns

-6.94%

Alembic Pharma

807.45 +9.90 (0.01%)

1Yr Returns

-23.93%

J.B.Chemicals & Pharma

1674.4 +28.55 (0.02%)

1Yr Returns

+62.01%